|
Feb 17
|
GlaxoSmithKline Pharmaceuticals Ltd (BOM:500660) Q3 2025 Earnings Call Highlights: Strong ...
|
|
Feb 15
|
GSK shares shorted by leading U.S. hedge fund, The Times reports
|
|
Feb 15
|
Here's Why We're Wary Of Buying GSK's (LON:GSK) For Its Upcoming Dividend
|
|
Feb 14
|
Hedge fund Citadel takes short position in GSK, FT reports
|
|
Feb 13
|
ViiV Healthcare and the pan-Canadian Pharmaceutical Alliance (pCPA) successfully finalize negotiations for APRETUDE for HIV-1 Pre-Exposure Prophylaxis
|
|
Feb 12
|
Some May Be Optimistic About GSK's (LON:GSK) Earnings
|
|
Feb 11
|
Goldman Sachs Turns Bearish On Vaccine Maker Dynavax Amid Shingles And Hepatitis B Uncertainty
|
|
Feb 10
|
Recent uptick might appease GSK plc (LON:GSK) institutional owners after losing 7.8% over the past year
|
|
Jan 29
|
Earnings Preview: GSK (GSK) Q4 Earnings Expected to Decline
|
|
Jan 29
|
GSK announces EMA accepted for review the MAA for depemokimab
|
|
Jan 29
|
The RFK Jr. Effect: Biotech Stocks Brace For 'Games' In Senate Hearings
|
|
Jan 27
|
GSK and Oxford researchers to create cancer vaccine to stop disease developing
|
|
Jan 27
|
Trending tickers: Nvidia, Alphabet, Alibaba, Novo Nordisk and GSK
|